Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Floreal | Beauty & Personal Care | 25.7% | 89th pct | 35 |
| Maigrinvei Georgia | Beauty & Personal Care | 25.2% | 86th pct | 35 |
| Kalta Bedniereba | Beauty & Personal Care | 0.4% | 9th pct | 35 |
| Satsalo Momsakhureba | Beauty & Personal Care | -2.4% | 6th pct | 35 |
| Akademia | Beauty & Personal Care | — | no FY data | 35 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Satsalo Momsakhureba | Floreal | Kalta Bedniereba | Maigrinvei Georgia | Akademia |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 53.7% | 67.3% | 42.9% | 57.1% | — |
| EBITDA Margin | -2.4% | 25.7% | 0.4% | 25.2% | — |
| EBITDAR | 1,779 | 2,219 | 898 | 1,781 | — |
| EBITDAR Margin | 20.3% | 26.7% | 12.5% | 25.8% | — |
| EBIT Margin | -4.8% | 13.9% | -0.1% | 25.1% | — |
| Net Profit Margin | -2.5% | 19.1% | 0.5% | 24.4% | — |
| Operating Expense % of Sales | 56.1% | 41.6% | 42.5% | 31.9% | — |
| Returns | |||||
| Return on Assets (ROA) | -3.8% | 11.6% | 1.3% | 36.5% | — |
| Return on Equity (ROE) | N/A | 14.6% | 14.6% | 37.9% | — |
| ROIC [EBIT / Invested Capital] | |||||
| -13.1% |
| 12.6% |
| -0.9% |
| 70.1% |
| — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 81.4% | 17.9% | 24.0% | 0.0% | — |
| Debt-to-Equity | -4.32x | 0.22x | 2.78x | 0.00x | — |
| Debt-to-EBITDA | N/A | 1.15x | 23.40x | 0.00x | — |
| Equity-to-Assets | -18.8% | 79.7% | 8.6% | 96.4% | — |
| Net Debt | 4,327 | -1,698 | 478 | -1,967 | — |
| Cash & Equivalents | 400 | 4,141 | 232 | 1,967 | — |
| Total Debt | 4,727 | 2,442 | 710 | N/A | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.70x | 7.51x | 0.95x | 27.70x | — |
| Quick Ratio | 0.70x | 4.96x | 0.95x | 27.70x | — |
| Cash Ratio | 0.06x | 3.81x | 0.11x | 11.91x | — |
| Total Current Assets | 4,730 | 8,169 | 2,085 | 4,573 | — |
| Total Current Liabilities | 6,722 | 1,087 | 2,200 | 165 | — |
| Inventory | N/A | 2,774 | -1 | N/A | — |
| Trade Receivables | 187 | 2,634 | 13 | 93 | — |
| Trade Payables | 2,046 | 290 | 1,850 | 119 | — |
| Net Working Capital | -1,992 | 7,081 | -115 | 4,408 | — |
| Net Working Capital % of Revenue | -22.7% | 85.3% | -1.6% | 63.9% | — |
| Trade Working Capital | -1,860 | 5,118 | -1,839 | -26 | — |
| Trade Working Capital % of Revenue | -21.2% | 61.6% | -25.6% | -0.4% | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | 0.98x | -2902.38x | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | 372.7 | -0.1 | N/A | — |
| Receivables Turnover | 46.98x | 3.15x | 551.99x | 74.19x | — |
| Days Sales Outstanding (DSO) | 7.8 | 115.8 | 0.7 | 4.9 | — |
| Payables Turnover | 1.99x | 9.36x | 2.22x | 24.93x | — |
| Days Payable Outstanding (DPO) | 183.7 | 39.0 | 164.6 | 14.6 | — |
| Cash Conversion Cycle | -175.9 days | 449.5 days | -164.0 days | -9.7 days | — |
| Asset Turnover | 1.51x | 0.61x | 2.43x | 1.50x | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | -722 | 2,592 | 125 | N/A | — |
| Free Cash Flow (OCF − Capex proxy) | -722 | 2,581 | -9 | N/A | — |
| Cash Conversion (OCF / EBITDA) | N/A | 121.5% | 411.7% | N/A | — |
| Dividends Declared | N/A | 0 | N/A | N/A | — |
| Dividend Payout Ratio | N/A | 0.0% | N/A | N/A | — |